Evidence map›Paper›PMID 26563159›Full record

ArticleJournal of clinical immunology2015

FAS Haploinsufficiency Caused by Extracellular Missense Mutations Underlying Autoimmune Lymphoproliferative Syndrome.

María Gabriela Simesen de Bielke, Laura Perez, Judith Yancoski, João Bosco Oliveira, Silvia Danielian

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of clinical immunology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Regulation of apoptosis by ubiquitination in liver cancer.American journal of cancer research · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

María Gabriela Simesen de BielkeLaboratorio de Biología Molecular Inmunología, Servicio de Inmunología y Reumatología, Hospital de Pediatría S.A.M.I.C. "Prof. Dr. Juan P. Garrahan", Combate de los Pozos N° 1881 (CPA: C 1245 AAM), Ciudad Autónoma de Buenos Aires, República Argentina. gabysimesen@gmail.com.
Laura PerezLaboratorio de Inmunología Humoral, Servicio de Inmunología y Reumatología, Hospital de Pediatría S.A.M.I.C. "Prof. Dr. Juan P. Garrahan", Buenos Aires, Argentina.
Judith YancoskiLaboratorio de Biología Molecular Inmunología, Servicio de Inmunología y Reumatología, Hospital de Pediatría S.A.M.I.C. "Prof. Dr. Juan P. Garrahan", Combate de los Pozos N° 1881 (CPA: C 1245 AAM), Ciudad Autónoma de Buenos Aires, República Argentina.
João Bosco OliveiraInstituto de Medicina Integral Prof. Fernando Figueira-IMIP, Recife, PE, Brazil.
Silvia DanielianLaboratorio de Biología Molecular Inmunología, Servicio de Inmunología y Reumatología, Hospital de Pediatría S.A.M.I.C. "Prof. Dr. Juan P. Garrahan", Combate de los Pozos N° 1881 (CPA: C 1245 AAM), Ciudad Autónoma de Buenos Aires, República Argentina.
Garrahan Hospital · ARInstituto de Medicina Integral Professor Fernando Figueira · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mutations in the FAS gene are the most common cause of Autoimmune Lymphoproliferative Syndrome (ALPS), and the majority of them affect the intracellular domain of FAS protein, particularly the region termed death domain. However, approximately one third of these mutations affect the extracellular region of FAS and most are stop codons, with very few missense changes having been described to date. We previously described 7 patients with a FAS missense extracellular mutation, C107Y, two in homozygozity and 5 in heterozygosity. We investigated here the mechanistic effects of this mutation and observed that the homozygous patients did not show any FAS surface expression, while the heterozygous patients had diminished receptor expression. Aiming to understand why a missense mutation was abolishing receptor expression, we analyzed intracellular FAS protein trafficking using fluorescent fusion proteins of wild type FAS, two missense extracellular mutants (FAS-C107Y and FAS-C104Y) and one missense change localized in the intracellular region, FAS-D260E. The FAS-C107Y and FAS-C104Y mutants failed to reach the cell surface, being retained at the endoplasmic reticulum, unlike the WT or the FAS-D260E which were clearly expressed at the plasma membrane. These results support haploinsufficiency as the underlying mechanism involved in the pathogenesis of ALPS caused by extracellular FAS missense mutations.

Indexed as

AllelesApoptosisArgentinaAutoimmune Lymphoproliferative SyndromeExtracellular Spacefas ReceptorHaploinsufficiencyHEK293 CellsHumansMutation, MissensePedigreeProtein EngineeringProtein Structure, TertiaryProtein TransportRecombinant Fusion ProteinsFAS protein, humanfas ReceptorRecombinant Fusion ProteinsALPSapoptosisFAShaploinsufficiency

Identifiers

PMID26563159
OpenAlexW2178005843

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.